Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
audEERING is a leading provider of AI-based audio intelligence and vocal biomarker technology, specializing in the detection of health states and emotions through speech analysis. The company's proprietary platform, devAIce, utilizes advanced deep learning algorithms to extract and analyze thousands of acoustic features to identify patterns associated with various medical conditions. audEERING's solutions are primarily utilized in clinical research and digital health applications to provide objective, non-invasive monitoring for indications such as depression, Parkinson's disease, and respiratory illnesses. By leveraging the voice as a diagnostic tool, the company enables remote patient monitoring and early intervention strategies. Their technology is backed by extensive academic research and is used by major pharmaceutical companies to enhance clinical trial endpoints.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AudEERING.